Global Non Vascular Stent Market

Non Vascular Stent Comprehensive Study by Type (Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stent, Others), End-User (Hospitals, Ambulatory Surgical Centers), Material Type (Metallic Stents, Non-metallic Stents) Players and Region - Global Market Outlook to 2030

Non Vascular Stent Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Non Vascular Stent Market Scope
Non-Vascular Stents are a type of stent that can be used for a variety of purposes, including esophageal, biliary, bronchial, colonic, and tracheal implantations. They're mostly used to carve a passage through the veins and arteries that transport lymph and blood. In addition, the human body has a network of ducts and capillaries that transfer fluids necessary for physiological functions throughout the body. The primary purpose of a non-vascular stent is to maintain the patency of stenotic arteries. They're also inserted into obstructed vessels to obtrude the narrowing vessel walls and enhance fluid flow through the artery and veins. Pulmonary stents are used to widen restricted airways and aid the breathing process in conditions such as chronic obstructive pulmonary disease, central airway obstruction, and asthma. Increasing technological and material breakthroughs are assisting in the development of, particularly engineered stents for a variety of indications. The market for non-vascular stents is growing due to the rising frequency of chronic disorders. Advances in technology, as well as a growing demand for minimally invasive operations, are fueling the industry's growth.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketNorth America
Largest MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledBecton, Dickinson and Company (United States), Boston Scientific Corporation (United States), CONMED Corporation (United States), Cook Medical (United States), ELLA - CS, s.r.o. (Czechia), Glaukos Corporation (United States), HOBBS MEDICAL INC (United States) and Medtronic (Ireland)
CAGR4.8%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Non Vascular Stent market throughout the predicted period.

Becton, Dickinson and Company (United States), Boston Scientific Corporation (United States), CONMED Corporation (United States), Cook Medical (United States), ELLA - CS, s.r.o. (Czechia), Glaukos Corporation (United States), HOBBS MEDICAL INC (United States) and Medtronic (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Micro-Tech (Nanjing) Co. Ltd (China) and W. L. Gore & Associates Inc. (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Non Vascular Stent market by Type and Region with country level break-up.

On the basis of geography, the market of Non Vascular Stent has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Singapore, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Spain, Rest of Europe), MEA (Saudi Arabia, Turkey, Israel, United Arab Emirates, South Africa, Rest of Africa), North America (United States, Canada, Mexico). Asia Pacific region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In February 2023 , Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, has agreed to acquire Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents1 to strengthen its GI EndoTherapy product portfolio capabilities, and in turn, contributing to improving patient outcome through comprehensive solutions
October 2020- Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction. and In 2020, Boston Scientific Corporation has introduced the TAXUS Element Paclitaxel-Eluting Coronary Stent System, which represents the company's third-generation drug-eluting stent (DES) technology. It is specifically designed for coronary stenting, providing both strength and flexibility.
Clinical studies conducted in the United States in support of a PMA approval must be conducted under the Investigational Device Exemptions (IDE) regulation, 21 CFR Part 812. FDA believes that the intravascular stents addressed by this guidance document are significant risk devices as defined in 21 CFR 812.3(m),1 and as such, are not exempt from the requirement to submit an investigational device exemption (IDE) application (21 CFR 812.2(b), 812.20(a)(1). When an IDE application is required, a sponsor must not begin a clinical trial in humans in the United States until FDA has approved the application (21 CFR 812.20(a)(2), 812.42).

Influencing Trend:
Technological Developments in Non-Vascular Stents

Market Growth Drivers:
Growing Prevalence of Gastrointestinal Cancer and Growing Geriatric Population & Prevalence of Chronic and Other Diseases

Challenges:
Complications Associated with Non-vascular Stents

Restraints:
Several Regulatory Factors

Opportunities:
Growing Research and Development Activities

Key Target Audience
Manufacturers of Non-Vascular Stent, Suppliers of Non-Vascular Stent, Wholesalers, Distributors and Retailers of Non-Vascular Stent, Healthcare Industry, Governmental Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Gastrointestinal Stents
  • Pulmonary (Airway) Stents
  • Urological Stent
  • Others
By End-User
  • Hospitals
  • Ambulatory Surgical Centers

By Material Type
  • Metallic Stents
  • Non-metallic Stents

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Rest of Europe
  • MEA
    • Saudi Arabia
    • Turkey
    • Israel
    • United Arab Emirates
    • South Africa
    • Rest of Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Gastrointestinal Cancer
      • 3.2.2. Growing Geriatric Population & Prevalence of Chronic and Other Diseases
    • 3.3. Market Challenges
      • 3.3.1. Complications Associated with Non-vascular Stents
    • 3.4. Market Trends
      • 3.4.1. Technological Developments in Non-Vascular Stents
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Non Vascular Stent, by Type, End-User, Material Type and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Non Vascular Stent (Value)
      • 5.2.1. Global Non Vascular Stent by: Type (Value)
        • 5.2.1.1. Gastrointestinal Stents
        • 5.2.1.2. Pulmonary (Airway) Stents
        • 5.2.1.3. Urological Stent
        • 5.2.1.4. Others
      • 5.2.2. Global Non Vascular Stent by: End-User (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Ambulatory Surgical Centers
      • 5.2.3. Global Non Vascular Stent by: Material Type (Value)
        • 5.2.3.1. Metallic Stents
        • 5.2.3.2. Non-metallic Stents
      • 5.2.4. Global Non Vascular Stent Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Singapore
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Spain
          • 5.2.4.3.7. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Saudi Arabia
          • 5.2.4.4.2. Turkey
          • 5.2.4.4.3. Israel
          • 5.2.4.4.4. United Arab Emirates
          • 5.2.4.4.5. South Africa
          • 5.2.4.4.6. Rest of Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Non Vascular Stent (Volume)
      • 5.3.1. Global Non Vascular Stent by: Type (Volume)
        • 5.3.1.1. Gastrointestinal Stents
        • 5.3.1.2. Pulmonary (Airway) Stents
        • 5.3.1.3. Urological Stent
        • 5.3.1.4. Others
      • 5.3.2. Global Non Vascular Stent by: End-User (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Ambulatory Surgical Centers
      • 5.3.3. Global Non Vascular Stent by: Material Type (Volume)
        • 5.3.3.1. Metallic Stents
        • 5.3.3.2. Non-metallic Stents
      • 5.3.4. Global Non Vascular Stent Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Singapore
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Spain
          • 5.3.4.3.7. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Saudi Arabia
          • 5.3.4.4.2. Turkey
          • 5.3.4.4.3. Israel
          • 5.3.4.4.4. United Arab Emirates
          • 5.3.4.4.5. South Africa
          • 5.3.4.4.6. Rest of Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Non Vascular Stent (Price)
      • 5.4.1. Global Non Vascular Stent by: Type (Price)
  • 6. Non Vascular Stent: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Becton, Dickinson and Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CONMED Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cook Medical (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ELLA - CS, s.r.o. (Czechia)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Glaukos Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. HOBBS MEDICAL INC (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Medtronic (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Non Vascular Stent Sale, by Type, End-User, Material Type and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Non Vascular Stent (Value)
      • 7.2.1. Global Non Vascular Stent by: Type (Value)
        • 7.2.1.1. Gastrointestinal Stents
        • 7.2.1.2. Pulmonary (Airway) Stents
        • 7.2.1.3. Urological Stent
        • 7.2.1.4. Others
      • 7.2.2. Global Non Vascular Stent by: End-User (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Ambulatory Surgical Centers
      • 7.2.3. Global Non Vascular Stent by: Material Type (Value)
        • 7.2.3.1. Metallic Stents
        • 7.2.3.2. Non-metallic Stents
      • 7.2.4. Global Non Vascular Stent Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Singapore
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Spain
          • 7.2.4.3.7. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Saudi Arabia
          • 7.2.4.4.2. Turkey
          • 7.2.4.4.3. Israel
          • 7.2.4.4.4. United Arab Emirates
          • 7.2.4.4.5. South Africa
          • 7.2.4.4.6. Rest of Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Non Vascular Stent (Volume)
      • 7.3.1. Global Non Vascular Stent by: Type (Volume)
        • 7.3.1.1. Gastrointestinal Stents
        • 7.3.1.2. Pulmonary (Airway) Stents
        • 7.3.1.3. Urological Stent
        • 7.3.1.4. Others
      • 7.3.2. Global Non Vascular Stent by: End-User (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Ambulatory Surgical Centers
      • 7.3.3. Global Non Vascular Stent by: Material Type (Volume)
        • 7.3.3.1. Metallic Stents
        • 7.3.3.2. Non-metallic Stents
      • 7.3.4. Global Non Vascular Stent Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Singapore
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Spain
          • 7.3.4.3.7. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Saudi Arabia
          • 7.3.4.4.2. Turkey
          • 7.3.4.4.3. Israel
          • 7.3.4.4.4. United Arab Emirates
          • 7.3.4.4.5. South Africa
          • 7.3.4.4.6. Rest of Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Non Vascular Stent (Price)
      • 7.4.1. Global Non Vascular Stent by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Non Vascular Stent: by Type(USD Million)
  • Table 2. Non Vascular Stent Gastrointestinal Stents , by Region USD Million (2018-2023)
  • Table 3. Non Vascular Stent Pulmonary (Airway) Stents , by Region USD Million (2018-2023)
  • Table 4. Non Vascular Stent Urological Stent , by Region USD Million (2018-2023)
  • Table 5. Non Vascular Stent Others , by Region USD Million (2018-2023)
  • Table 6. Non Vascular Stent: by End-User(USD Million)
  • Table 7. Non Vascular Stent Hospitals , by Region USD Million (2018-2023)
  • Table 8. Non Vascular Stent Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 9. Non Vascular Stent: by Material Type(USD Million)
  • Table 10. Non Vascular Stent Metallic Stents , by Region USD Million (2018-2023)
  • Table 11. Non Vascular Stent Non-metallic Stents , by Region USD Million (2018-2023)
  • Table 12. South America Non Vascular Stent, by Country USD Million (2018-2023)
  • Table 13. South America Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 14. South America Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 15. South America Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 16. Brazil Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 17. Brazil Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 18. Brazil Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 19. Argentina Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 20. Argentina Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 21. Argentina Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 22. Rest of South America Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 23. Rest of South America Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 24. Rest of South America Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 25. Asia Pacific Non Vascular Stent, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 28. Asia Pacific Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 29. China Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 30. China Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 31. China Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 32. Japan Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 33. Japan Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 34. Japan Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 35. India Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 36. India Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 37. India Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 38. South Korea Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 39. South Korea Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 40. South Korea Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 41. Singapore Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 42. Singapore Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 43. Singapore Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 44. Australia Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 45. Australia Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 46. Australia Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 50. Europe Non Vascular Stent, by Country USD Million (2018-2023)
  • Table 51. Europe Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 52. Europe Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 53. Europe Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 54. Germany Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 55. Germany Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 56. Germany Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 57. France Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 58. France Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 59. France Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 60. Italy Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 61. Italy Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 62. Italy Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 63. United Kingdom Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 64. United Kingdom Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 65. United Kingdom Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 66. Netherlands Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 67. Netherlands Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 68. Netherlands Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 69. Spain Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 70. Spain Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 71. Spain Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 72. Rest of Europe Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 73. Rest of Europe Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 74. Rest of Europe Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 75. MEA Non Vascular Stent, by Country USD Million (2018-2023)
  • Table 76. MEA Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 77. MEA Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 78. MEA Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 79. Saudi Arabia Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 80. Saudi Arabia Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 81. Saudi Arabia Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 82. Turkey Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 83. Turkey Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 84. Turkey Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 85. Israel Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 86. Israel Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 87. Israel Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 88. United Arab Emirates Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 89. United Arab Emirates Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 90. United Arab Emirates Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 91. South Africa Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 92. South Africa Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 93. South Africa Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 94. Rest of Africa Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 95. Rest of Africa Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 96. Rest of Africa Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 97. North America Non Vascular Stent, by Country USD Million (2018-2023)
  • Table 98. North America Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 99. North America Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 100. North America Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 101. United States Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 102. United States Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 103. United States Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 104. Canada Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 105. Canada Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 106. Canada Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 107. Mexico Non Vascular Stent, by Type USD Million (2018-2023)
  • Table 108. Mexico Non Vascular Stent, by End-User USD Million (2018-2023)
  • Table 109. Mexico Non Vascular Stent, by Material Type USD Million (2018-2023)
  • Table 110. Non Vascular Stent Sales: by Type(K Units)
  • Table 111. Non Vascular Stent Sales Gastrointestinal Stents , by Region K Units (2018-2023)
  • Table 112. Non Vascular Stent Sales Pulmonary (Airway) Stents , by Region K Units (2018-2023)
  • Table 113. Non Vascular Stent Sales Urological Stent , by Region K Units (2018-2023)
  • Table 114. Non Vascular Stent Sales Others , by Region K Units (2018-2023)
  • Table 115. Non Vascular Stent Sales: by End-User(K Units)
  • Table 116. Non Vascular Stent Sales Hospitals , by Region K Units (2018-2023)
  • Table 117. Non Vascular Stent Sales Ambulatory Surgical Centers , by Region K Units (2018-2023)
  • Table 118. Non Vascular Stent Sales: by Material Type(K Units)
  • Table 119. Non Vascular Stent Sales Metallic Stents , by Region K Units (2018-2023)
  • Table 120. Non Vascular Stent Sales Non-metallic Stents , by Region K Units (2018-2023)
  • Table 121. South America Non Vascular Stent Sales, by Country K Units (2018-2023)
  • Table 122. South America Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 123. South America Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 124. South America Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 125. Brazil Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 126. Brazil Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 127. Brazil Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 128. Argentina Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 129. Argentina Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 130. Argentina Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 131. Rest of South America Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 132. Rest of South America Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 133. Rest of South America Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 134. Asia Pacific Non Vascular Stent Sales, by Country K Units (2018-2023)
  • Table 135. Asia Pacific Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 136. Asia Pacific Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 137. Asia Pacific Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 138. China Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 139. China Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 140. China Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 141. Japan Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 142. Japan Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 143. Japan Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 144. India Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 145. India Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 146. India Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 147. South Korea Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 148. South Korea Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 149. South Korea Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 150. Singapore Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 151. Singapore Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 152. Singapore Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 153. Australia Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 154. Australia Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 155. Australia Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 156. Rest of Asia-Pacific Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 157. Rest of Asia-Pacific Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 158. Rest of Asia-Pacific Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 159. Europe Non Vascular Stent Sales, by Country K Units (2018-2023)
  • Table 160. Europe Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 161. Europe Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 162. Europe Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 163. Germany Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 164. Germany Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 165. Germany Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 166. France Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 167. France Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 168. France Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 169. Italy Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 170. Italy Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 171. Italy Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 172. United Kingdom Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 173. United Kingdom Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 174. United Kingdom Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 175. Netherlands Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 176. Netherlands Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 177. Netherlands Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 178. Spain Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 179. Spain Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 180. Spain Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 181. Rest of Europe Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 182. Rest of Europe Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 183. Rest of Europe Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 184. MEA Non Vascular Stent Sales, by Country K Units (2018-2023)
  • Table 185. MEA Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 186. MEA Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 187. MEA Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 188. Saudi Arabia Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 189. Saudi Arabia Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 190. Saudi Arabia Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 191. Turkey Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 192. Turkey Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 193. Turkey Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 194. Israel Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 195. Israel Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 196. Israel Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 197. United Arab Emirates Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 198. United Arab Emirates Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 199. United Arab Emirates Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 200. South Africa Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 201. South Africa Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 202. South Africa Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 203. Rest of Africa Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 204. Rest of Africa Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 205. Rest of Africa Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 206. North America Non Vascular Stent Sales, by Country K Units (2018-2023)
  • Table 207. North America Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 208. North America Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 209. North America Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 210. United States Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 211. United States Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 212. United States Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 213. Canada Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 214. Canada Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 215. Canada Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 216. Mexico Non Vascular Stent Sales, by Type K Units (2018-2023)
  • Table 217. Mexico Non Vascular Stent Sales, by End-User K Units (2018-2023)
  • Table 218. Mexico Non Vascular Stent Sales, by Material Type K Units (2018-2023)
  • Table 219. Non Vascular Stent: by Type(USD/Units)
  • Table 220. Company Basic Information, Sales Area and Its Competitors
  • Table 221. Company Basic Information, Sales Area and Its Competitors
  • Table 222. Company Basic Information, Sales Area and Its Competitors
  • Table 223. Company Basic Information, Sales Area and Its Competitors
  • Table 224. Company Basic Information, Sales Area and Its Competitors
  • Table 225. Company Basic Information, Sales Area and Its Competitors
  • Table 226. Company Basic Information, Sales Area and Its Competitors
  • Table 227. Company Basic Information, Sales Area and Its Competitors
  • Table 228. Non Vascular Stent: by Type(USD Million)
  • Table 229. Non Vascular Stent Gastrointestinal Stents , by Region USD Million (2025-2030)
  • Table 230. Non Vascular Stent Pulmonary (Airway) Stents , by Region USD Million (2025-2030)
  • Table 231. Non Vascular Stent Urological Stent , by Region USD Million (2025-2030)
  • Table 232. Non Vascular Stent Others , by Region USD Million (2025-2030)
  • Table 233. Non Vascular Stent: by End-User(USD Million)
  • Table 234. Non Vascular Stent Hospitals , by Region USD Million (2025-2030)
  • Table 235. Non Vascular Stent Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 236. Non Vascular Stent: by Material Type(USD Million)
  • Table 237. Non Vascular Stent Metallic Stents , by Region USD Million (2025-2030)
  • Table 238. Non Vascular Stent Non-metallic Stents , by Region USD Million (2025-2030)
  • Table 239. South America Non Vascular Stent, by Country USD Million (2025-2030)
  • Table 240. South America Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 241. South America Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 242. South America Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 243. Brazil Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 244. Brazil Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 245. Brazil Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 246. Argentina Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 247. Argentina Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 248. Argentina Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 249. Rest of South America Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 250. Rest of South America Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 251. Rest of South America Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 252. Asia Pacific Non Vascular Stent, by Country USD Million (2025-2030)
  • Table 253. Asia Pacific Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 254. Asia Pacific Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 255. Asia Pacific Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 256. China Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 257. China Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 258. China Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 259. Japan Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 260. Japan Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 261. Japan Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 262. India Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 263. India Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 264. India Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 265. South Korea Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 266. South Korea Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 267. South Korea Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 268. Singapore Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 269. Singapore Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 270. Singapore Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 271. Australia Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 272. Australia Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 273. Australia Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 274. Rest of Asia-Pacific Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 275. Rest of Asia-Pacific Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 276. Rest of Asia-Pacific Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 277. Europe Non Vascular Stent, by Country USD Million (2025-2030)
  • Table 278. Europe Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 279. Europe Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 280. Europe Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 281. Germany Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 282. Germany Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 283. Germany Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 284. France Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 285. France Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 286. France Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 287. Italy Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 288. Italy Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 289. Italy Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 290. United Kingdom Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 291. United Kingdom Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 292. United Kingdom Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 293. Netherlands Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 294. Netherlands Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 295. Netherlands Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 296. Spain Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 297. Spain Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 298. Spain Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 299. Rest of Europe Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 300. Rest of Europe Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 301. Rest of Europe Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 302. MEA Non Vascular Stent, by Country USD Million (2025-2030)
  • Table 303. MEA Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 304. MEA Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 305. MEA Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 306. Saudi Arabia Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 307. Saudi Arabia Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 308. Saudi Arabia Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 309. Turkey Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 310. Turkey Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 311. Turkey Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 312. Israel Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 313. Israel Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 314. Israel Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 315. United Arab Emirates Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 316. United Arab Emirates Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 317. United Arab Emirates Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 318. South Africa Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 319. South Africa Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 320. South Africa Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 321. Rest of Africa Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 322. Rest of Africa Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 323. Rest of Africa Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 324. North America Non Vascular Stent, by Country USD Million (2025-2030)
  • Table 325. North America Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 326. North America Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 327. North America Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 328. United States Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 329. United States Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 330. United States Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 331. Canada Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 332. Canada Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 333. Canada Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 334. Mexico Non Vascular Stent, by Type USD Million (2025-2030)
  • Table 335. Mexico Non Vascular Stent, by End-User USD Million (2025-2030)
  • Table 336. Mexico Non Vascular Stent, by Material Type USD Million (2025-2030)
  • Table 337. Non Vascular Stent Sales: by Type(K Units)
  • Table 338. Non Vascular Stent Sales Gastrointestinal Stents , by Region K Units (2025-2030)
  • Table 339. Non Vascular Stent Sales Pulmonary (Airway) Stents , by Region K Units (2025-2030)
  • Table 340. Non Vascular Stent Sales Urological Stent , by Region K Units (2025-2030)
  • Table 341. Non Vascular Stent Sales Others , by Region K Units (2025-2030)
  • Table 342. Non Vascular Stent Sales: by End-User(K Units)
  • Table 343. Non Vascular Stent Sales Hospitals , by Region K Units (2025-2030)
  • Table 344. Non Vascular Stent Sales Ambulatory Surgical Centers , by Region K Units (2025-2030)
  • Table 345. Non Vascular Stent Sales: by Material Type(K Units)
  • Table 346. Non Vascular Stent Sales Metallic Stents , by Region K Units (2025-2030)
  • Table 347. Non Vascular Stent Sales Non-metallic Stents , by Region K Units (2025-2030)
  • Table 348. South America Non Vascular Stent Sales, by Country K Units (2025-2030)
  • Table 349. South America Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 350. South America Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 351. South America Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 352. Brazil Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 353. Brazil Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 354. Brazil Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 355. Argentina Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 356. Argentina Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 357. Argentina Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 358. Rest of South America Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 359. Rest of South America Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 360. Rest of South America Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 361. Asia Pacific Non Vascular Stent Sales, by Country K Units (2025-2030)
  • Table 362. Asia Pacific Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 363. Asia Pacific Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 364. Asia Pacific Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 365. China Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 366. China Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 367. China Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 368. Japan Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 369. Japan Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 370. Japan Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 371. India Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 372. India Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 373. India Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 374. South Korea Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 375. South Korea Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 376. South Korea Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 377. Singapore Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 378. Singapore Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 379. Singapore Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 380. Australia Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 381. Australia Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 382. Australia Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 383. Rest of Asia-Pacific Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 384. Rest of Asia-Pacific Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 385. Rest of Asia-Pacific Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 386. Europe Non Vascular Stent Sales, by Country K Units (2025-2030)
  • Table 387. Europe Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 388. Europe Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 389. Europe Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 390. Germany Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 391. Germany Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 392. Germany Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 393. France Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 394. France Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 395. France Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 396. Italy Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 397. Italy Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 398. Italy Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 399. United Kingdom Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 400. United Kingdom Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 401. United Kingdom Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 402. Netherlands Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 403. Netherlands Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 404. Netherlands Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 405. Spain Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 406. Spain Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 407. Spain Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 408. Rest of Europe Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 409. Rest of Europe Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 410. Rest of Europe Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 411. MEA Non Vascular Stent Sales, by Country K Units (2025-2030)
  • Table 412. MEA Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 413. MEA Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 414. MEA Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 415. Saudi Arabia Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 416. Saudi Arabia Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 417. Saudi Arabia Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 418. Turkey Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 419. Turkey Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 420. Turkey Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 421. Israel Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 422. Israel Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 423. Israel Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 424. United Arab Emirates Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 425. United Arab Emirates Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 426. United Arab Emirates Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 427. South Africa Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 428. South Africa Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 429. South Africa Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 430. Rest of Africa Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 431. Rest of Africa Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 432. Rest of Africa Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 433. North America Non Vascular Stent Sales, by Country K Units (2025-2030)
  • Table 434. North America Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 435. North America Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 436. North America Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 437. United States Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 438. United States Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 439. United States Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 440. Canada Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 441. Canada Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 442. Canada Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 443. Mexico Non Vascular Stent Sales, by Type K Units (2025-2030)
  • Table 444. Mexico Non Vascular Stent Sales, by End-User K Units (2025-2030)
  • Table 445. Mexico Non Vascular Stent Sales, by Material Type K Units (2025-2030)
  • Table 446. Non Vascular Stent: by Type(USD/Units)
  • Table 447. Research Programs/Design for This Report
  • Table 448. Key Data Information from Secondary Sources
  • Table 449. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Non Vascular Stent: by Type USD Million (2018-2023)
  • Figure 5. Global Non Vascular Stent: by End-User USD Million (2018-2023)
  • Figure 6. Global Non Vascular Stent: by Material Type USD Million (2018-2023)
  • Figure 7. South America Non Vascular Stent Share (%), by Country
  • Figure 8. Asia Pacific Non Vascular Stent Share (%), by Country
  • Figure 9. Europe Non Vascular Stent Share (%), by Country
  • Figure 10. MEA Non Vascular Stent Share (%), by Country
  • Figure 11. North America Non Vascular Stent Share (%), by Country
  • Figure 12. Global Non Vascular Stent: by Type K Units (2018-2023)
  • Figure 13. Global Non Vascular Stent: by End-User K Units (2018-2023)
  • Figure 14. Global Non Vascular Stent: by Material Type K Units (2018-2023)
  • Figure 15. South America Non Vascular Stent Share (%), by Country
  • Figure 16. Asia Pacific Non Vascular Stent Share (%), by Country
  • Figure 17. Europe Non Vascular Stent Share (%), by Country
  • Figure 18. MEA Non Vascular Stent Share (%), by Country
  • Figure 19. North America Non Vascular Stent Share (%), by Country
  • Figure 20. Global Non Vascular Stent: by Type USD/Units (2018-2023)
  • Figure 21. Global Non Vascular Stent share by Players 2023 (%)
  • Figure 22. Global Non Vascular Stent share by Players (Top 3) 2023(%)
  • Figure 23. Global Non Vascular Stent share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton, Dickinson and Company (United States) Revenue: by Geography 2023
  • Figure 27. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 29. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. CONMED Corporation (United States) Revenue: by Geography 2023
  • Figure 31. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 32. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 33. ELLA - CS, s.r.o. (Czechia) Revenue, Net Income and Gross profit
  • Figure 34. ELLA - CS, s.r.o. (Czechia) Revenue: by Geography 2023
  • Figure 35. Glaukos Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Glaukos Corporation (United States) Revenue: by Geography 2023
  • Figure 37. HOBBS MEDICAL INC (United States) Revenue, Net Income and Gross profit
  • Figure 38. HOBBS MEDICAL INC (United States) Revenue: by Geography 2023
  • Figure 39. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 40. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 41. Global Non Vascular Stent: by Type USD Million (2025-2030)
  • Figure 42. Global Non Vascular Stent: by End-User USD Million (2025-2030)
  • Figure 43. Global Non Vascular Stent: by Material Type USD Million (2025-2030)
  • Figure 44. South America Non Vascular Stent Share (%), by Country
  • Figure 45. Asia Pacific Non Vascular Stent Share (%), by Country
  • Figure 46. Europe Non Vascular Stent Share (%), by Country
  • Figure 47. MEA Non Vascular Stent Share (%), by Country
  • Figure 48. North America Non Vascular Stent Share (%), by Country
  • Figure 49. Global Non Vascular Stent: by Type K Units (2025-2030)
  • Figure 50. Global Non Vascular Stent: by End-User K Units (2025-2030)
  • Figure 51. Global Non Vascular Stent: by Material Type K Units (2025-2030)
  • Figure 52. South America Non Vascular Stent Share (%), by Country
  • Figure 53. Asia Pacific Non Vascular Stent Share (%), by Country
  • Figure 54. Europe Non Vascular Stent Share (%), by Country
  • Figure 55. MEA Non Vascular Stent Share (%), by Country
  • Figure 56. North America Non Vascular Stent Share (%), by Country
  • Figure 57. Global Non Vascular Stent: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Becton, Dickinson and Company (United States)
  • Boston Scientific Corporation (United States)
  • CONMED Corporation (United States)
  • Cook Medical (United States)
  • ELLA - CS, s.r.o. (Czechia)
  • Glaukos Corporation (United States)
  • HOBBS MEDICAL INC (United States)
  • Medtronic (Ireland)
Additional players considered in the study are as follows:
Micro-Tech (Nanjing) Co. Ltd (China) , W. L. Gore & Associates Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 152 Pages 93 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Non Vascular Stent Market Quantitative research analysis
Global Non Vascular Stent Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Non Vascular Stent Market are by type [Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stent and Others], by end use application [].
The Non Vascular Stent Market is gaining popularity and expected to see strong valuation by 2030.
  • Growing Prevalence of Gastrointestinal Cancer
  • Growing Geriatric Population & Prevalence of Chronic and Other Diseases

Know More About Global Non Vascular Stent Market Report?

Have a Query? Click Here

Other Related Reports

Microneedle Patches Comprehensive Study by Type (Dissolving Type, Insoluble Type), Application (Medical, Cosmetics) Players and Region - Global Market Outlook to 2030
$ 3500
Weight Monitoring Devices Comprehensive Study by Type (Digital Weight Monitoring Device, Analog Weight Monitoring Device), Category (Wired, Wireless), End Use (Hospital, Ambulatory Surgical Centers, ...
$ 3450
Smart Patches Comprehensive Study by Type (Re use patch, Disposable patch), Application (Medical & health care, Cosmetics and Personal care, Sport and fitness, Others), Sale channel (Online, Offline,...
$ 3650
Managed Equipment Sevices Comprehensive Study by Service Providers (Single-Vendor, Multiple-Vendor), End Users (Hospitals, Clinics, Healthcare Organization), Service (Radiology, Pathology, Radiothera...
$ 3500
Home Therapeutic Equipments Comprehensive Study by Type (Home Respiratory Therapy Equipment, Home Dialysis Equipment, Home IV Equipment, Other), Application (For Children, For Adults), Portability (S...
$ 3350
Cold Plasma Implant Treatment Devices Comprehensive Study by Type (Handheld Devices, Commercial Systems), Application (Orthopedic Implant, Dental Implant), End User (Medical Devices Companies, Hospit...
$ 3350